doi: 10.1093/annonc/mdn120.
Epub 2008 Mar 28.
MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
- PMID: 18375524
- PMCID: PMC2613432
- DOI: 10.1093/annonc/mdn120
Item in Clipboard
MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
Ann Oncol.
2008 May.
No abstract available
Similar articles
-
[Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].Rev Esp Med Nucl. 2000 Jun;19(3):244-6. Rev Esp Med Nucl. 2000. PMID: 11062090 Spanish. No abstract available.
-
[Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].Rev Esp Med Nucl. 2001 Oct;20(6):503-5. doi: 10.1016/s0212-6982(01)71998-2. Rev Esp Med Nucl. 2001. PMID: 11578586 Spanish. No abstract available.
-
[Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].Rev Esp Med Nucl. 2002 Nov-Dec;21(6):437-8. doi: 10.1016/s0212-6982(02)72122-8. Rev Esp Med Nucl. 2002. PMID: 12425893 Spanish. No abstract available.
-
HER2 as a prognostic factor in breast cancer.Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
-
Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.Anticancer Res. 2000 May-Jun;20(3B):2219-22. Anticancer Res. 2000. PMID: 10928181 Review.
Cited by
-
Magnetic resonance differential analysis for different hormone receptor expression status in HER-2-positive breast cancer.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Jan 28;48(1):68-75. doi: 10.11817/j.issn.1672-7347.2023.220096. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36935179 Free PMC article. Chinese, English.
References
-
- Arpino G, Weiss H, Lee AV, et al. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst. 2005 Sep 7;97(17):1254–61. - PubMed
-
- Ponzone R, Montemurro F, Maggiorotto F, et al. Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer. Ann Oncol. 2006 Nov;17(11):1631–6. - PubMed
-
- American College of Radiology . Breast imaging reporting and data system atlas (BI-RADS atlas) American College of Radiology; Reston, VA: 2003.
-
- Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol. 2003 May 15;21(10):1973–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
